Zacharon Pharmaceuticals, Inc.
5626 Oberlin Drive
4 articles with Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Announces Potential $200 Million Collaboration With Pfizer Inc. to Develop Drugs for Multiple Rare Disorders
Zacharon Pharmaceuticals Completes $3.5 Million Series A Financing, Receives More Than $2.2 Million in National Institutes of Health (NIH) Grants